Identification of the Gene Encoding Alkylglycerol Monooxygenase Defines a Third Class of Tetrahydrobiopterin-Dependent Enzymes

Total Page:16

File Type:pdf, Size:1020Kb

Identification of the Gene Encoding Alkylglycerol Monooxygenase Defines a Third Class of Tetrahydrobiopterin-Dependent Enzymes Identification of the gene encoding alkylglycerol monooxygenase defines a third class of tetrahydrobiopterin-dependent enzymes Katrin Watschingera, Markus A. Kellera, Georg Golderera, Martin Hermannb, Manuel Maglioneb, Bettina Sargc, Herbert H. Lindnerc, Albin Hermetterd, Gabriele Werner-Felmayera, Robert Konrate, Nicolas Hulof, and Ernst R. Wernera,1 aDivision of Biological Chemistry, Biocenter, Innsbruck Medical University, Fritz-Pregl-Strasse 3, A-6020 Innsbruck, Austria; bDepartment of Visceral-, Transplant-, and Thoracic Surgery, Daniel-Swarovski-Research Laboratory, Innsbruck Medical University, Innrain 66, A-6020 Innsbruck, Austria; cDivision of Clinical Biochemistry, Biocenter, Innsbruck Medical University, Fritz-Pregl-Strasse 3, A-6020 Innsbruck, Austria; dInstitute of Biochemistry, Graz University of Technology, Petersgasse 12/2, A-8010 Graz, Austria; eDepartment of Structural and Computational Biology, Max F. Perutz Laboratories, University of Vienna, Vienna Biocenter Campus 5, A-1030 Vienna, Austria; and fCentre Medical Universitaire and Structural Biology and Bioinformatics Department, 1 Rue Michel-Servet, CH-1211 Geneva 4, Switzerland Edited by Stephen J. Benkovic, Pennsylvania State University, University Park, PA, and approved June 22, 2010 (received for review February 25, 2010) Alkylglycerol monooxygenase (glyceryl-ether monooxygenase, EC step, this reaction yields the radical gas nitric oxide and citrulline 1.14.16.5) is the only enzyme known to cleave the O-alkyl bond of (4, 5). Nitric oxide synthases are required for a number of ether lipids which are essential components of brain membranes, physiological processes such as blood pressure regulation, neuro- protect the eye from cataract, interfere or mediate signalling transmission, and host defense against pathogens (6–8). The fifth processes, and are required for spermatogenesis. Along with phe- tetrahydrobiopterin-dependent enzymatic reaction catalyzed by nylalanine hydroxylase, tyrosine hydroxylase, tryptophan hydro- alkylglycerol monooxygenase (glyceryl-ether monooxygenase, xylase, and nitric oxide synthase, alkylglycerol monooxygenase EC 1.14.16.5, Fig. 1A) has been first described already in 1964 is one of five known enzymatic reactions which depend on tetra- (9). Despite several attempts to purify and characterize this hydrobiopterin. Although first described in 1964, no sequence membrane bound protein (10), it still belonged to the currently had been assigned to this enzyme so far since it lost activity upon 1,297 enzymes lacking sequence assignment which are called BIOCHEMISTRY protein purification attempts. A functional library screen using orphan enzymes (11). Alkylglycerol monooxygenase is the only pools of plasmids of a rat liver expression library transfected to enzyme known to cleave the O-alkyl ether bond in alkylglycerols, CHO cells was also unsuccessful. We therefore selected human yielding an aldehyde and a glycerol derivative. The aldehyde is candidate genes by bioinformatic approaches and by proteomic detoxified by conversion to the corresponding acid by fatty analysis of partially purified enzyme and tested alkylglycerol aldehyde dehydrogenase (EC 1.2.1.48, gene symbol ALDH3A2, monooxygenase activity in CHO cells transfected with expression Fig. S1). Tetrahydrobiopterin leaves the reaction as “quinoid” 6,7 plasmids. Transmembrane protein 195, a predicted membrane pro- [8H]-dihydrobiopterin (10) and is recycled to tetrahydrobiopterin tein with unassigned function which occurs in bilateral animals, by quinoid dihydropteridine reductase (Fig. S1, EC 1.5.1.34, gene was found to encode for tetrahydrobiopterin-dependent alkylgly- symbol QDPR). The formation of 6,7[8H]-dihydrobiopterin from cerol monooxygenase. This sequence assignment was confirmed 4a-hydroxy-tetrahydrobiopterin, the initial enzymatic product by injection of transmembrane protein 195 cRNA into Xenopus formed from tetrahydrobiopterin, may be facilitated by 4a-carbi- laevis oocytes. Transmembrane protein 195 shows no sequence nolamine dehydratase (EC 4.2.1.96, PCBD1) like for aromatic homology to aromatic amino acid hydroxylases or nitric oxide amino acid hydroxylases (12), but this has not yet been demon- synthases, but contains the fatty acid hydroxylase motif. This motif strated for alkylglycerol monooxygenase. is found in enzymes which contain a diiron center and which carry out hydroxylations of lipids at aliphatic carbon atoms like alkylgly- Results cerol monooxygenase. This sequence assignment suggests that Protein Purification, Functional Expression Screening Attempts, and alkylglycerol monooxygenase forms a distinct third group among Bioinformatic Candidate Gene Selection. Although we used a robust, tetrahydrobiopterin-dependent enzymes. and sensitive assay for alkylglycerol monooxygenase activity (13), attempts to purify the protein from male rat liver, the source EC 1.14.16.5 ∣ glyceryl-ether monooxygenase ∣ nitric oxide synthase ∣ with the highest activity observed (10), failed due to the instability phenylalanine hydroxylase ∣ transmembrane protein 195 of the enzyme activity (Table S1), which could not be fully solubilized (Fig. S2). The necessity of HPLC analysis which etrahydrobiopterin is a metabolite structurally related to the has a capacity of about 40 assays a day precluded a full, single Tvitamins folic acid and riboflavin by sharing the common clone functional expression screen which would require testing pterin (pyrimido[4,5-b]pyrazine) backbone. In contrast to the of about 100,000 clones. We therefore tried an approach using two vitamins which have to be taken up by the diet, however, plasmid pools (14). Transfection of CHO cells with 196 plasmid tetrahydrobiopterin is synthesized in animals from guanosine pools containing about 2,500 individual clones each of a rat liver triphosphate by the consecutive action of three enzymes (1). Five enzymatic reactions are known to depend essentially on the Author contributions: K.W., M.A.K., G.G., M.H., M.M., G.W.-F., and E.R.W. designed tetrahydrobiopterin cofactor (2). In three of these reactions, a research; K.W., M.A.K., G.G., M.H., M.M., B.S., H.H.L., R.K., N.H., and E.R.W. performed hydroxy function is introduced into the aromatic ring of pheny- research; A.H. contributed new reagents/analytic tools; K.W., M.A.K., G.G., M.H., M.M., lalanine, tyrosine, and tryptophan by aromatic amino acid hydro- B.S., H.H.L., G.W.-F., R.K., N.H., and E.R.W. analyzed data; and E.R.W. wrote the paper. xylases, which are required for the degradation of phenylalanine The authors declare no conflict of interest. and for the biosynthesis of catecholamines and serotonin, impor- This article is a PNAS Direct Submission. tant neurotransmitters and metabolism regulators. The fourth Freely available online through the PNAS open access option. enzymatic reaction requiring tetrahydrobiopterin is catalyzed 1To whom correspondence should be addressed. E-mail: [email protected]. by nitric oxide synthases, which occur in three isoforms (3). After This article contains supporting information online at www.pnas.org/lookup/suppl/ hydroxylation of the guanidino nitrogen of L-arginine in a first doi:10.1073/pnas.1002404107/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1002404107 PNAS Early Edition ∣ 1of6 Downloaded by guest on October 1, 2021 PAH human ABCH3 O ( )n PAH mouse PAH danre OH alkylglycerol TPH1 human TPH1 mouse aromatic OH TPH1 danre TPH2 human amino acid O tetrahydrobiopterin 2 TPH2 mouse hydroxylases alkylglycerol monooxygenase TPH2 danre (EC 1.14.16.5) TH human TH mouse H O 2 6,7[8H]-dihydrobiopterin TH danre NOS1 mouse OH NOS1 human OH NOS1 danre OH glycerol CH NOS3 human ( ) 3 nitric oxide O n NOS3 mouse synthases OH NOS2 human OH NOS2 mouse O NOS2a danre OH CH NOS2b danre H ( ) 3 n TMEM195 human alkylglycerol primary product fatty aldehyde TMEM195 mouse mono- (unstable) TMEM195 danre oxygenase 0.4 0.00.2 Fig. 1. Alkylglycerol monooxygenase. (A) The alkylglycerol monooxygenase reaction. Alkylglycerols are thought to be hydroxylated on the aliphatic carbon of the sn1 side chain adjacent to the ether bond in a tetrahydrobiopterin-dependent way in a mechanism sharing features with tetrahydrobiopterin-dependent enzymatic hydroxylation of aromatic amino acids. The resulting primary product, a hemiacetal, is thought to decay rapidly to the respective fatty aldehyde and glycerol (9, 10, 19). Alkylglycerol monooxygenase accepts a wide range of alkylglycerol lipids and phospholipids, and is currently the only enzyme known to cleave the O-alkyl ether bond in these compounds (see Fig. S1 for further details). Alkylglycerols with O-alkyl chain lengths of 12–20 carbon atoms are good substrates, thus n ranges from 10–18. (B) Phylogenetic tree of tetrahydrobiopterin-dependent enzymes. Protein sequences of genes for tetrahydrobiopterin- dependent enzymes from man, mouse, and zebrafish were selected from protein databases, aligned by ClustalW (Gonnet Matrix) and an UPMGA (unweighted pair group method using arithmetic averages) tree with Poisson correction drawn by MEGA4.0 using the default parameters (29). For details and accession numbers of protein sequences see Table S2. No sequence homology occurred across the three groups which differ in the form of iron required for catalysis. The scale bar gives a measure of the average fraction of amino acids exchanged between the sequences. expression library, however, did not yield activity above back- dehydrogenase) yielded a two orders of magnitude higher read- ground. Therefore
Recommended publications
  • Developmental Plasticity and Circuit Mechanisms of Dopamine-Modulated Aggression Darshini Mahadevia Submitted in Partial Fulfill
    Developmental plasticity and circuit mechanisms of dopamine-modulated aggression Darshini Mahadevia Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy under the Executive Committee of the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2018 © 2018 Darshini Mahadevia All rights reserved ABSTRACT Developmental plasticity and circuit mechanisms of dopamine-modulated aggression Darshini Mahadevia Aggression and violence pose a significant public health concern to society. Aggression is a highly conserved behavior that shares common biological correlates across species. While aggression developed as an evolutionary adaptation to competition, its untimely and uncontrolled expression is maladaptive and presents itself in a number of neuropsychiatric disorders. A mechanistic hypothesis for pathological aggression links aberrant behavior with heightened dopamine function. However, while dopamine hyper-activity is a neural correlate of aggression, the developmental aspects and circuit level contributions of dopaminergic signaling have not been elucidated. In this dissertation, I aim to address these questions regarding the specifics of dopamine function in a murine model of aggressive behavior. In chapter I, I provide a review of the literature that describes the current state of research on aggression. I describe the background elements that lay the foundation for experimental questions and original data presented in later chapters. I introduce, in detail, published studies that describe the clinical manifestation and epidemiological spread, the dominant categories, the anatomy and physiology, and the pharmacology of aggression, with a particular emphasis on the dopaminergic system. Finally, I describe instances of genetic and environmental risk factors impacting aggression, concluding with studies revealing an important role for interactions among genetics, environmental factors, and age in the development of aggression.
    [Show full text]
  • The Bone Marrow Niche in the Pathogenesis of Multiple Myeloma a Role for Wnt Signaling and Adrenomedullin
    A role for Wnt signaling and Adrenomedullin and signaling Wnt for A role Myeloma Multiple of niche in the pathogenesis marrow The bone The bone marrow niche in the pathogenesis of Multiple Myeloma A role for Wnt signaling and Adrenomedullin pracownia DTP i grafiki www.przygotowalniaDTP.pl ISBN 978-83-63861-16-2 Kinga Anna Kocemba okladka_nowa.indd 1-3 2014-01-20 11:57:46 The bone marrow niche in the pathogenesis of Multiple Myeloma A role for Wnt signaling and Adrenomedullin The bone marrow niche in the pathogenesis of Multiple Myeloma A role for Wnt signaling and Adrenomedullin Kinga Anna Kocemba The research described in this thesis was funded by the Dutch Cancer Society Editing Przygotowalnia Pracownia DTP i Grafiki Graphic design and typesetting Przygotowalnia Pracownia DTP i Grafiki Cover: Antelope Canyon, Arizona, USA by Kinga Anna Kocemba © Copyright by Kinga Anna Kocemba ISBN 978-83-63861-16-2 Amsterdam–Kraków 2014 Pracownia DTP i Grafiki ul. Łużycka 71c/9 30–693 Kraków [email protected] www.przygotowalniaDTP.pl Moim rodzicom To my parents The bone marrow niche in the pathogenesis of Multiple Myeloma A role for Wnt signaling and Adrenomedullin academisch proefschrift ter verkrijging van de graad van doctor aan de Universiteit van Amsterdam op gezag van de Rector Magnificus prof. dr. D.C. van den Boom ten overstaan van een door het college voor promoties ingestelde commissie, in het openbaar te verdedigen in de Agnietenkapel op donderdag 6 maart 2014, te 14:00 uur door Kinga Anna Kocemba geboren te Oświęcim, Polen Promotiecommissie promotor Prof.
    [Show full text]
  • JAD 5478.Pdf
    JAD-05478; No of Pages 9 Journal of Affective Disorders xxx (2012) xxx–xxx Contents lists available at SciVerse ScienceDirect Journal of Affective Disorders journal homepage: www.elsevier.com/locate/jad Research report Association of TPH1, TPH2, and 5HTTLPR with PTSD and depressive symptoms Armen K. Goenjian a,b,e,⁎, Julia N. Bailey c,d, David P. Walling b, Alan M. Steinberg a, Devon Schmidt b, Uma Dandekar d, Ernest P. Noble e a UCLA/Duke University National Center for Child Traumatic Stress, Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles (UCLA), United States b Collaborative Neuroscience Network, Garden Grove, CA 92845, United States c Department of Epidemiology, UCLA School of Public Health, Los Angeles, CA, United States d Epilepsy Genetics/Genomics Laboratories, VA GLAHS, Los Angeles, CA, United States e Alcohol Research Center, Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, United States article info abstract Article history: Objective: To examine the potential contribution of the serotonin hydroxylase (TPH1 and Received 29 January 2012 TPH2) genes, and the serotonin transporter promoter polymorphism (5HTTLPR) to the unique Accepted 5 February 2012 and pleiotropic risk of PTSD symptoms and depressive symptoms. Available online xxxx Methods: Participants included 200 adults exposed to the 1988 Spitak earthquake from 12 multigenerational families (3 to 5 generations). Severity of trauma exposure, PTSD, and de- Keywords: pressive symptoms were assessed using standard psychometric instruments. Pedigree-based Genetics variance component analysis was used to assess the association between select genes and PTSD the phenotypes. Depression Results: After adjusting for age, sex, exposure and environmental variables, there was a signif- Tryptophan hydroxylase icant association of PTSD symptoms with the ‘t’ allele of TPH1 SNP rs2108977 (pb0.004), Serotonin transporter explaining 3% of the phenotypic variance.
    [Show full text]
  • WO 2Ull/13162O Al
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date Χ 1 / A 1 27 October 2011 (27.10.2011) WO 2Ull/13162o Al (51) International Patent Classification: AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, C12N 9/02 (2006.01) A61K 38/44 (2006.01) CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, A61K 38/17 (2006.01) DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, (21) International Application Number: KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, PCT/EP20 11/056142 ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, (22) International Filing Date: NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, 18 April 201 1 (18.04.201 1) SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (25) Filing Language: English (84) Designated States (unless otherwise indicated, for every (26) Publication Langi English kind of regional protection available): ARIPO (BW, GH, (30) Priority Data: GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, 10160368.6 19 April 2010 (19.04.2010) EP ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, (71) Applicants (for all designated States except US): MEDI- EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, FT, LT, LU, ZINISCHE UNIVERSITAT INNSBRUCK [AT/AT]; LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, Christoph-Probst-Platz, Innrain 52, A-6020 Innsbruck SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, (AT).
    [Show full text]
  • Pharmacogenomic Characterization in Bipolar Spectrum Disorders
    pharmaceutics Review Pharmacogenomic Characterization in Bipolar Spectrum Disorders Stefano Fortinguerra 1,2 , Vincenzo Sorrenti 1,2,3 , Pietro Giusti 2, Morena Zusso 2 and Alessandro Buriani 1,2,* 1 Maria Paola Belloni Center for Personalized Medicine, Data Medica Group (Synlab Limited), 35131 Padova, Italy; [email protected] (S.F.); [email protected] (V.S.) 2 Department of Pharmaceutical & Pharmacological Sciences, University of Padova, 35131 Padova, Italy; [email protected] (P.G.); [email protected] (M.Z.) 3 Bendessere™ Study Center, Solgar Italia Multinutrient S.p.A., 35131 Padova, Italy * Correspondence: [email protected] Received: 25 November 2019; Accepted: 19 December 2019; Published: 21 December 2019 Abstract: The holistic approach of personalized medicine, merging clinical and molecular characteristics to tailor the diagnostic and therapeutic path to each individual, is steadily spreading in clinical practice. Psychiatric disorders represent one of the most difficult diagnostic challenges, given their frequent mixed nature and intrinsic variability, as in bipolar disorders and depression. Patients misdiagnosed as depressed are often initially prescribed serotonergic antidepressants, a treatment that can exacerbate a previously unrecognized bipolar condition. Thanks to the use of the patient’s genomic profile, it is possible to recognize such risk and at the same time characterize specific genetic assets specifically associated with bipolar spectrum disorder, as well as with the individual response to the various therapeutic options. This provides the basis for molecular diagnosis and the definition of pharmacogenomic profiles, thus guiding therapeutic choices and allowing a safer and more effective use of psychotropic drugs. Here, we report the pharmacogenomics state of the art in bipolar disorders and suggest an algorithm for therapeutic regimen choice.
    [Show full text]
  • Flavin-Containing Monooxygenases: Mutations, Disease and Drug Response Phillips, IR; Shephard, EA
    Flavin-containing monooxygenases: mutations, disease and drug response Phillips, IR; Shephard, EA For additional information about this publication click this link. http://qmro.qmul.ac.uk/jspui/handle/123456789/1015 Information about this research object was correct at the time of download; we occasionally make corrections to records, please therefore check the published record when citing. For more information contact [email protected] Flavin-containing monooxygenases: mutations, disease and drug response Ian R. Phillips1 and Elizabeth A. Shephard2 1School of Biological and Chemical Sciences, Queen Mary, University of London, Mile End Road, London E1 4NS, UK 2Department of Biochemistry and Molecular Biology, University College London, Gower Street, London WC1E 6BT, UK Corresponding author: Shephard, E.A. ([email protected]). and, thus, contribute to drug development. This review Flavin-containing monooxygenases (FMOs) metabolize considers the role of FMOs and their genetic variants in numerous foreign chemicals, including drugs, pesticides disease and drug response. and dietary components and, thus, mediate interactions between humans and their chemical environment. We Mechanism and structure describe the mechanism of action of FMOs and insights For catalysis FMOs require flavin adenine dinucleotide gained from the structure of yeast FMO. We then (FAD) as a prosthetic group, NADPH as a cofactor and concentrate on the three FMOs (FMOs 1, 2 and 3) that are molecular oxygen as a cosubstrate [5,6]. In contrast to most important for metabolism of foreign chemicals in CYPs FMOs accept reducing equivalents directly from humans, focusing on the role of the FMOs and their genetic NADPH and, thus, do not require accessory proteins.
    [Show full text]
  • Molecule of the Month: Phenylalanine Hydroxylase
    Molecule of the Month: Phenylalanine Hydroxylase An unusual cofactor is used in the synthesis of aromatic amino acids The Protein Alphabet The proteins that make up the skin, muscle, hair, bones and other organs in your body are primarily composed of a set of 20 building blocks, called amino acids. Amino acids are the alphabet in the protein language: when combined in a specific order, they make up meaningful structures (proteins) with varied and specific functions. Amino acids have distinct shapes, sizes, charges and other characteristics. Many amino acids are synthesized in your body from breakdown products of sugars and fats, or are converted from other amino acids by the action of specific enzymes. However, a few of them, called essential amino acids, cannot be synthesized or converted in your body and have to be obtained from the food you eat. Phenylalanine is one such essential amino acid. It is closely related to another amino acid, tyrosine, which just has an additional hydroxyl (OH) group. Liver cells contain an enzyme called phenylalanine hydroxylase, which can add this group and convert phenylalanine to tyrosine. Thus as long as this enzyme is functional and there is a reasonable supply of phenylalanine, tyrosine can be synthesized in your body and does not have to be included in the food that you eat. Phenylalanine Hydroxylase Four molecules of phenylalanine hydroxylase interact to form a tetramer, which is the functional unit for this enzyme. Each molecule in the tetramer is organized into three domains: a regulatory domain, a catalytic domain where the enzyme activity resides and a tetramerization domain that assembles four chains into the tetramer.
    [Show full text]
  • Investigation of Candidate Genes and Mechanisms Underlying Obesity
    Prashanth et al. BMC Endocrine Disorders (2021) 21:80 https://doi.org/10.1186/s12902-021-00718-5 RESEARCH ARTICLE Open Access Investigation of candidate genes and mechanisms underlying obesity associated type 2 diabetes mellitus using bioinformatics analysis and screening of small drug molecules G. Prashanth1 , Basavaraj Vastrad2 , Anandkumar Tengli3 , Chanabasayya Vastrad4* and Iranna Kotturshetti5 Abstract Background: Obesity associated type 2 diabetes mellitus is a metabolic disorder ; however, the etiology of obesity associated type 2 diabetes mellitus remains largely unknown. There is an urgent need to further broaden the understanding of the molecular mechanism associated in obesity associated type 2 diabetes mellitus. Methods: To screen the differentially expressed genes (DEGs) that might play essential roles in obesity associated type 2 diabetes mellitus, the publicly available expression profiling by high throughput sequencing data (GSE143319) was downloaded and screened for DEGs. Then, Gene Ontology (GO) and REACTOME pathway enrichment analysis were performed. The protein - protein interaction network, miRNA - target genes regulatory network and TF-target gene regulatory network were constructed and analyzed for identification of hub and target genes. The hub genes were validated by receiver operating characteristic (ROC) curve analysis and RT- PCR analysis. Finally, a molecular docking study was performed on over expressed proteins to predict the target small drug molecules. Results: A total of 820 DEGs were identified between
    [Show full text]
  • TRANSLATIONALLY by AMPK a Dissertation
    CHOLESTEROL 7 ALPHA-HYDROXYLASE IS REGULATED POST- TRANSLATIONALLY BY AMPK A dissertation submitted to Kent State University in partial fulfillment of the requirements for the Degree of Doctor of Philosophy By Mauris E.C. Nnamani May 2009 Dissertation written by Mauris E. C. Nnamani B.S, Kent State University, 2006 Ph.D., Kent State University, 2009 Approved by Diane Stroup Advisor Gail Fraizer Members, Doctoral Dissertation Committee S. Vijayaraghavan Arne Gericke Jennifer Marcinkiewicz Accepted by Robert Dorman , Director, School of Biomedical Science John Stalvey , Dean, Collage of Arts and Sciences ii TABLE OF CONTENTS LIST OF FIGURES……………………………………………………………..vi ACKNOWLEDGMENTS……………………………………………………..viii CHAPTER I: INTRODUCTION……………………………………….…........1 a. Bile Acid Synthesis…………………………………………….……….2 i. Importance of Bile Acid Synthesis Pathway………………….….....2 ii. Bile Acid Transport..…………………………………...…...………...3 iii. Bile Acid Synthesis Pathway………………………………………...…4 iv. Classical Bile Acid Synthesis Pathway…..……………………..…..8 Cholesterol 7 -hydroxylase (CYP7A1)……..........………….....8 Transcriptional Regulation of Cholesterol 7 -hydroxylase by Bile Acid-activated FXR…………………………….....…10 CYP7A1 Transcriptional Repression by SHP-dependant Mechanism…………………………………………………...10 CYP7A1 Transcriptional Repression by SHP-independent Mechanism……………………………………..…………….…….11 CYP7A1 Transcriptional Repression by Activated Cellular Kinase…….…………………………...…………………….……12 v. Alternative/ Acidic Bile Acid Synthesis Pathway…………......…….12 Sterol 27-hydroxylase (CYP27A1)……………….…………….12
    [Show full text]
  • Drug-Induced Movement Disorders
    Medical Management of Early PD Samer D. Tabbal, M.D. May 2016 Associate Professor of Neurology Director of The Parkinson Disease & Other Movement Disorders Program Mobile: +961 70 65 89 85 email: [email protected] Conflict of Interest Statement No drug company pays me any money Outline So, you diagnosed Parkinson disease .Natural history of the disease .When to start drug therapy? .Which drug to use first for symptomatic treatment? ● Levodopa vs dopamine agonist vs MAOI Natural History of Parkinson Disease Before levodopa: Death within 10 years After levodopa: . “Honeymoon” period (~ 5-7 years) . Motor (ON/OFF) fluctuations & dyskinesias: ● Drug therapy effective initially ● Surgical intervention by 10-15 years - Deep brain stimulation (DBS) therapy Motor Response Dyskinesia 5-7 yrs >10 yrs Dyskinesia ON state ON state OFF state OFF state time time Several days Several hours 1-2 hour Natural History of Parkinson Disease Prominent gait impairment and autonomic symptoms by 20-25 years (Merola 2011) Behavioral changes before or with motor symptoms: . Sleep disorders . Depression . Anxiety . Hallucinations, paranoid delusions Dementia at anytime during the illness . When prominent or early: diffuse Lewy body disease Symptoms of Parkinson Disease Motor Symptoms Sensory Symptoms Mental Symptoms: . Cognitive and psychiatric Autonomic Symptoms Presenting Symptoms of Parkinson Disease Mood disorders: depression and lack of motivation Sleep disorders: “acting out dreams” and nightmares Early motor symptoms: Typically Unilateral . Rest tremor: chin, arms or legs or “inner tremor” . Bradykinesia: focal and generalized slowness . Rigidity: “muscle stiffness or ache” Also: (usually no early postural instability) . Facial masking with hypophonia: “does not smile anymore” or “looks unhappy all the time” .
    [Show full text]
  • Methotrexate Induces Hyperplasia of Enterochromaffin
    112 BPB Reports 4, 112-115 (2021) Vol. 4, No. 4 Report Methotrexate Induces Hyperplasia of Enterochromaffin Cells in Mouse Jejunum Takuji Machida,*,a Airi Tanaka,a Megumi Kobayashi,a Kohei Imai,a Masahiko Hirafuji,a,b and Kenji Iizukaa aDepartment of Pharmacological Sciences, School of Pharmaceutical Sciences, Health Sciences University of Hokkaido, 1757 Kanazawa, Ishikari-Tobetsu, Hokkaido 061-0293, Japan; bPresent address: School of Health Sciences, Iryo Sosei University, 5-5-1 Chuodai Iino, Iwaki, Fukushima 970-8551, Japan Received May 12, 2021; Accepted July 26, 2021 5-Hydroxytryptamine (5-HT) is synthesized by L-tryptophan hydroxylase (TPH) and is stored mainly in enterochromaffin cells of the mucosal epithelium. We previously reported that administration of methotrex- ate, an anticancer agent, to rats caused hyperplasia of enterochromaffin cells, and nitric oxide (NO) might be involved in the underlying mechanism. The aim of this study was to clarify the effect of methotrexate on hyper- plasia of enterochromaffin cells in mice. C57BL/6J mice were intraperitoneally injected with methotrexate or saline as a control. Methotrexate caused an increase in the number of TPH-expressing cells (i.e., enterochromaf- fin cells) in the jejunum. Methotrexate also increased inducible, but not constitutive, NOS mRNA expression. Our results indicate that methotrexate potentiates 5-HT synthesis in mice, as we previously found in rats. Key words methotrexate, intestine, 5-hydroxytriptamine, inducible nitric oxide synthase INTRODUCTION the effects of methotrexate are similar to those previously found in rats.4,6) The use of high doses of methotrexate, an anti-cancer drug, is associated with gastrointestinal damage, which leads to mal- MATERIALS AND METHODS absorption, diarrhea, and weight loss.1,2) In addition, metho- trexate causes moderate emesis in humans and experimental Materials Methotrexate was obtained from Pfizer Co., Ltd.
    [Show full text]
  • Electronic Supplementary Material (ESI) for Metallomics
    Electronic Supplementary Material (ESI) for Metallomics. This journal is © The Royal Society of Chemistry 2018 Uniprot Entry name Gene names Protein names Predicted Pattern Number of Iron role EC number Subcellular Membrane Involvement in disease Gene ontology (biological process) Id iron ions location associated 1 P46952 3HAO_HUMAN HAAO 3-hydroxyanthranilate 3,4- H47-E53-H91 1 Fe cation Catalytic 1.13.11.6 Cytoplasm No NAD biosynthetic process [GO:0009435]; neuron cellular homeostasis dioxygenase (EC 1.13.11.6) (3- [GO:0070050]; quinolinate biosynthetic process [GO:0019805]; response to hydroxyanthranilate oxygenase) cadmium ion [GO:0046686]; response to zinc ion [GO:0010043]; tryptophan (3-HAO) (3-hydroxyanthranilic catabolic process [GO:0006569] acid dioxygenase) (HAD) 2 O00767 ACOD_HUMAN SCD Acyl-CoA desaturase (EC H120-H125-H157-H161; 2 Fe cations Catalytic 1.14.19.1 Endoplasmic Yes long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; unsaturated fatty 1.14.19.1) (Delta(9)-desaturase) H160-H269-H298-H302 reticulum acid biosynthetic process [GO:0006636] (Delta-9 desaturase) (Fatty acid desaturase) (Stearoyl-CoA desaturase) (hSCD1) 3 Q6ZNF0 ACP7_HUMAN ACP7 PAPL PAPL1 Acid phosphatase type 7 (EC D141-D170-Y173-H335 1 Fe cation Catalytic 3.1.3.2 Extracellular No 3.1.3.2) (Purple acid space phosphatase long form) 4 Q96SZ5 AEDO_HUMAN ADO C10orf22 2-aminoethanethiol dioxygenase H112-H114-H193 1 Fe cation Catalytic 1.13.11.19 Unknown No oxidation-reduction process [GO:0055114]; sulfur amino acid catabolic process (EC 1.13.11.19) (Cysteamine
    [Show full text]